Posted by cipapo > 2017-01-11 06:56 | Report Abuse

dude...though I don't own anyway shares....the company already announced its a minor temporary minor impact on bursa la...why at 2.30am you still so interested in creating rumours on the forum?...haha...makes me wonder your intentions....
hovid still have a lot of stocks in their inventory...

pharmaniaga had similar problem back in year 2010....and they got back their license within 2 weeks and without any problems...

http://www.theedgemarkets.com/my/article/pharmaniaga-gets-back-manufacturing-licence

http://www.insage.com.my/ir/cmn/downloading.aspx?sFileName=57249&sReportType=CHM&sCompanyCode=PHARMA

In its statement to the exchange on Monday, Hovid said its distribution subsidiaries in Malaysia, Hong Kong and the Philippines would continue to market and sell the existing stocks held by them respectively.

in my opinion...hovid is just waiting for a strong rebound...

Posted by Diamond7 > 2017-01-11 07:12 | Report Abuse

Hovid’s EPS to drop 15% if production shuts down till end-March.
Hovid saids.... turnover per share would contract from 23.06 sen to 18.43 sen (-4.63 sen or -20.1%) while net assets per share would slip from 24.61 sen to 24.28 sen (-0.33 sen or -1.3%).

Posted by Diamond7 > 2017-01-11 07:15 | Report Abuse

EPS would drop by 0.33 sen, from 2.18 sen to 1.85 sen. That equates to a total earnings drop of RM2.705mil.

It invites NPRA to audit its facilities and Current Good Manufacturing Practice (cGMP) immediately thereafter;

* The authority re-issues the manufacturing licences by end-March; and

* Hovid resumes production activities by April 1.

Posted by pussycats > 2017-01-11 08:15 | Report Abuse

falling knife ... cut all sides

Posted by facai > 2017-01-11 08:38 | Report Abuse

use that high blood pressure medicine few years, need to buy some for standby in case cannot find from market since it expect mfc on April. need to seek doctors advice too if need to find that replacement...

Posted by fattycat > 2017-01-11 08:43 | Report Abuse

I had been working in a pharmacy b4.
hovid is a good brand .
too bad , the mistake is very very serious......

Posted by moneyinc > 2017-01-11 08:44 | Report Abuse

how if the licence cannot get back end of march ?this company will continue loss , and I think will falling to pn17 again

Posted by gohkimhock > 2017-01-11 08:48 | Report Abuse

i m sure the licence can get back. But the damage to the reputation is serious and might take a very long time to regain it.

Posted by ks5S > 2017-01-11 08:51 | Report Abuse

pharmaceutical business need huge capital. With the cash flow problem later, hovid is dead.

Posted by B4b4 > 2017-01-11 08:51 | Report Abuse

It will take some time to recover the confidence loss.

Posted by cooling > 2017-01-11 08:52 | Report Abuse

hahaha....which business do not need huge capital??...unless you sell your bekside...then its free...

Posted by cooling > 2017-01-11 09:03 | Report Abuse

http://aseanbac.com.my/_content/events/ABAM_Programme_Book_2016.pdf

being an exporter to 50 countries...they contribute positively to the country income and also providing jobs...

Posted by ks5S > 2017-01-11 09:11 | Report Abuse

you want me to kokok you-kah ?

Posted by steveooikp > 2017-01-11 09:13 | Report Abuse

actually almost every week got this type of share....
go down very fast, once you catch it and it will go up very fast....

so which will be the next counter?

Please share....

Posted by GOD_OF_KLSE > 2017-01-11 09:18 | Report Abuse

yesterday bot 285 sen .... 31 sen now .... q 32 sen

Posted by iambigshark > 2017-01-11 09:28 | Report Abuse

coming down again

Posted by profit profits > 2017-01-11 09:30 | Report Abuse

This is the money printing machine for Hovid, if you kena stroke or potentially going to have stroke, you better donate money to Hovid and start taking this drug before too late.
For this drug, you will quitely buy more if u receive double the pill or double the dose.
http://my-live-03.slatic.net/p/5/tocovid-suprabio-200mg-30s-x-3-exp-july-2019-3350-89955561-1829127f67a2e6ac4b1e9a283aa339cd-catalog_233.jpg

Posted by Drago Tian > 2017-01-11 09:40 | Report Abuse

No show, sayur ta da.....

Posted by leno > 2017-01-11 11:33 | Report Abuse

tocovid is not stroke medicine. It is palm oil derive vit E supplement. Basically tocovid capsule contain a few drop of cooking oil. If no believe can ask any GP clinic or any pharmacies. Nobody eat tocovid. I mean ... anyone eat tocovid before ? Zero. Zip. Nadai. Ilek.

Posted by gcke > 2017-01-11 11:55 | Report Abuse

Looking at the Technical Price Charts to offer us as investors some guide-http://www.malaysiastock.biz/Stock-Chart.aspx?securitycode=7213
1.The stock is trending downwards;
2.MACD line showed high bearishness;
3.The counter is slightly now oversold.

Probability of price recovery in the near term(3 months) looks not promising.

Surprised me that the top management had not come out with any press statements to assure investors.In such situation,where the manufacturing licence is revoked,the implications to the profitability and sustainability of the company is adverse.Looked like the company does not have the business recovery plan to mitigate such adverse news.

They have to be more upfront publicly so that the investors know they are on top of things.We certainly want to know what reasonable corrective measures and steps will be taken by the company to meet with the regulatory requirements.

Such matter needs proper handling and communication by the company.

Just to share.

Posted by kevin5059 > 2017-01-11 12:01 | Report Abuse

According to Hovid, due to the licence issue, Hovid business is expected to drop by 15%. Assuming 0.34 was previous Hovid share price, then the fair value for the counter should be around 0.28. Warrant around 0.11.

So I think it will be a good buy around 0.28-0.3 and 0.11-0.13.

Posted by vincent27 > 2017-01-11 12:04 | Report Abuse

http://www.thesundaily.my/news/2123997

expects to see a RM37 million drop in turnover and RM2.7 million fall in earnings due to the closure in the first quarter of the year.

Posted by profit profits > 2017-01-11 15:21 | Report Abuse

Current price is lower than discounted price (-5 sen per share) due to no production.
http://www.bursamalaysia.com/market/listed-companies/company-announcements/5310861

Posted by kayubabi > 2017-01-11 16:45 | Report Abuse

now only this stock become pisang goreng panas. before this no movement at all. so sad i loss on paper already

Posted by AKUMAUKAYA > 2017-01-11 16:56 | Report Abuse

Do you think the management would just sit there do nothing? Pasti ada jalan punya…. Kena sabar .….

Posted by Orson Chin > 2017-01-11 18:28 | Report Abuse

What is bottom price for hovid ?

Posted by SapuMalaysia > 2017-01-11 19:32 | Report Abuse

Sad for this counter. Like this counter so much. Revoke the license is goddamn problem to the pharmaceutical manufacturing company. It can become crisis if fail to manage it. Not only the production loss /stop work/negative cashflow, the timeline to restore the license is a big question mark. Reputation and exports might be recall due to cGMP non-compliance.

Posted by whyisme > 2017-01-11 19:41 | Report Abuse

PN17

Posted by cooling > 2017-01-11 19:47 | Report Abuse

temporary....

http://www.theedgemarkets.com/my/article/pharmaceutical-body-commends-handling-hovid-issue

By Adela Megan Willy / The Edge Financial Daily | January 11, 2017 : 10:56 AM MYT

This article first appeared in The Edge Financial Daily, on January 11, 2017.


KUALA LUMPUR: The Malaysian Pharmaceutical Society (MPS) has applauded the health ministry, the National Pharmaceutical Regulatory Agency (NPRA) and Hovid Bhd for their transparency and accountability in addressing Hovid’s product recall and licence revocation.

“All parties acted fast in getting the information to the public,” said MPS president Amrahi Buang in a statement yesterday.

He was commenting on the “transparent, efficient and responsible” handling of the recent recall of Ternolol 50mg tablets by all three parties, as well as the subsequent cancellation of Hovid’s manufacturing licences.

“However, our main concern is the safety of the product users and we hope that all the medication in circulation is returned to Hovid soon,” Amrahi said.

Although it would not speculate about the root cause as the investigation is still ongoing, the MPS said the society and its members had helped made the message go viral on social media with other pharmacists to ensure that the recall information was shared widely.

Amrahi said the Malaysian public lack awareness of the regulatory process in the country, adding that the people are not well informed of how to check for registered products and are unclear about recall procedures.

“Due to the lack of understanding, many incorrect assumptions are made and shared on social media in an irresponsible manner,” he said.

Nevertheless, he said the NPRA is tasked with ensuring that therapeutic substances approved for the local market are safe, efficacious and of quality via product registration, licensing (manufacture, import and wholesale), monitoring of adverse drug reactions and market surveillance.

Amrahi added that the NPRA only approves a drug registration after it has undergone a stringent screening and approval process of between six and 18 months, depending on product classification.

Once a drug has been approved, regular post-market surveillance is done to ensure registration compliance.

Posted by limkokthye > 2017-01-11 21:18 | Report Abuse

buy when other is fearful,

Posted by limkokthye > 2017-01-11 21:18 | Report Abuse

msia apa pun boleh, keep buy now, later or sooner , apa pun sudah lupa

Posted by lloydlim > 2017-01-11 21:27 | Report Abuse

U guys forgotten April 1st is April Fool, no hope!

Posted by profit profits > 2017-01-11 23:43 | Report Abuse

Solution is so simple and straightforward, make the 10mcg packing box and tablets size as 3cm X 4cm, make the 5mcg box and tablet size as 2cm X 5cm. Even a blindman operator would NOT able to pack any tablet into wrong box because it would be either too long or too wide to fit in the box. POKAYOKE

Posted by soolee11 > 2017-01-12 05:41 | Report Abuse

A manufacturing company that loses its manufacturing licence even though it may be temporary, shows a total failure in management. Period.

Posted by Bizfuneng > 2017-01-12 08:33 | Report Abuse

THe CEO ought to be sacked. What a disgrace. In fact the whole board ought to be replaced.

Posted by profit profits > 2017-01-12 08:48 | Report Abuse

This is not the CEO's fault lah, he hires a QC person in charge Ong Bee Lan to take care of QC and this is first publicly reported QC problems. If he take no action and let the incidence happen again then you can blame the CEO.

Posted by Yuming > 2017-01-12 10:06 | Report Abuse

Actually now is lelong price, better pump in before boom, jz timing only. This company fundamental definitely good. Just a common small issue for this period. Even report come out, wont impact much la.... Even drop compared last Quarter, still in green of the net profit.

Posted by younginvestor92 > 2017-01-12 10:20 | Report Abuse

sure drop further, valuation still quite high

Posted by Taikoh > 2017-01-12 13:58 | Report Abuse

From now onwards, Ah Lan can stay at home and be housewife, a small negligible punishment for causing the risk to my investment, if I am the CEO I would sacked her immediately. First for the QC failure and than second for the poor handling of the Pharma audit leading to the withdrawal of the manufacturing license.

Posted by speakup > 2017-01-12 14:00 | Report Abuse

factory shut down....so what? can still up coz Hovid is cornered by syndicates.

Posted by Elitetrader > 2017-01-12 14:46 | Report Abuse

I wonder if the authorities had given them ample notice for corrective action before the suspension.

Posted by 10bagger10 > 2017-01-12 14:50 | Report Abuse

Posted by Yuming > Jan 12, 2017 10:06 AM | Report Abuse

Actually now is lelong price, better pump in before boom, jz timing only. This company fundamental definitely good. Just a common small issue for this period. Even report come out, wont impact much la.... Even drop compared last Quarter, still in green of the net profit.


At PE around 15 still a lelong price? u can accept it if u buy now and wait for 15 years to take back ur capital? can you forsee any future expansion which will contribute positively atm? are u serious? seriously?

Posted by Wk1983 > 2017-01-12 15:04 | Report Abuse

Its phase 2 expansion plan that will increase its capacity by 70% is expected to be operational in 1H 2017. Right?

The main problem is the reputational damage that may affect the sale performance (customer confidence) and business development efforts.

Posted by Yuming > 2017-01-12 15:07 | Report Abuse

Haha, everyone got own target n point. Trade on your own risk.

Posted by Littlefield > 2017-01-12 15:17 | Report Abuse

The top management staffs shall work 24 hours non stop to get all corrective actions to be taken in place immediately to shorten the reassessment audit by NPCP ASAP, and update the Board and investors daily. This disaster can be avoidable if management staffs and company policy is encourage implement of poke yoke on production system, and always eyes on top of news production improvements. Company and investors are suffering big losses.

Posted by skyz > 2017-01-12 16:51 | Report Abuse

lol poka yoke also come out

Posted by hinata > 2017-01-12 17:52 | Report Abuse

Good News coming stay tune!

Posted by cooling > 2017-01-12 18:15 | Report Abuse

thanks to panic sellers to let everyone collect cheap....new factory easily double up production this year...pharmaniaga learnt their lesson in 2010...let this round be a lesson to all to be a better company moving forward.

Posted by aceso > 2017-01-12 19:37 | Report Abuse

cooling you are right. Its knee jerk reflex of the market sentiment to the news. Im pretty sure the operator and shark took opportunity of this incident as well.. if 100million share on the first day. I really sympathize those who have sold earlier on. Again, i repeat. Im from pharma field. Hovid will get back their license eventually. They have enough resources to ride this wave through. IN fact, this issue doesnot involved efficacy, serious adverse event, so its minimal impact. The share price dropped really doesnt reflect the issue at hand. Fair value i say 0.32 factoring the losses with nil manufacturing till April.

Posted by aceso > 2017-01-12 19:38 | Report Abuse

By april, even they dont get full license... they are allowed to resume certain areas